Biomedicines | Free Full-Text | Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection
PDF) The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Nonalcoholic Fatty Liver Disease: Diagnosis and Management | AAFP
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
BioPredictive · FibroMax
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The “VARES” Italian multicenter study | Annals of Hepatology
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
PDF) How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index)?
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise | Nature Reviews Gastroenterology & Hepatology
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes - ScienceDirect
Non-invasive tests of non-alcoholic fatty liver disease | Chinese Medical Journal
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus | Journal of Investigative Medicine
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management
Clinical case: NAFLD
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | Request PDF
